Milray MC is a local contract research organization (CRO) providing a well tested full-service for the conduct of clinical trials (Phase I to IV) in Republic of Moldova. We are young company but have a team of well trained specialists according to the GCP requirements. Republic of Moldova became a very attractive spot for CT in the last decade. Moldova has a population of 3.6mln, a centralized healthcare system, dedicated doctors with experience in CT and friendly patients motivated to collaborate. Their motivation relies on the fact that standard care system offers fewer and less effective treatments. The populations are also largely treatment naive and ethnically homogenous, which facilitates the assessment of treatments with pharmacokinetics that vary with the patients’ genome. The organization of healthcare in Moldova channels patients into a small number of specialized centers, from which many patients who fit protocol criteria can be selected and treated at the same site. We can cover all main therapeutic areas like: oncology, cardiology, rheumatology, pulmonology, hematology, endocrinology, nephrology, etc., through our established network of top doctors in main hospitals of the country. We know in detail all local requirements of Regulatory Agencies for CT approval and are flexible in ensuring the success of the trial. Taking into account that Moldova is a Developing country, the prices of Milray MC are more attractable compared to European CRO, but we ensure the Quality Control of CCDRD (European CRO) for all performed Clinical Trials in Moldova.
